Shared and distinct phenotypes and functions of human CD161++ Vα7.2+ T cell subsets

Autor: Kurioka, A, Jahun, AS, Hannaway, RF, Walker, LJ, Fergusson, JR, Sverremark-Ekström, E, Corbett, AJ, Ussher, JE, Willberg, CB, Klenerman, P

Publikováno v: Frontiers in Immunology

Human mucosal-associated invariant T (MAIT) cells are an important T cell subset that are enriched in tissues and possess potent effector functions. Typically such cells are marked by their expression of Vα7.2-Jα33/Jα20/Jα12 T cell receptors, and

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::90c2c16288641dab326385acfe51a32a
https://ora.ox.ac.uk/objects/uuid:eb46b5c2-6340-4567-b80f-67d1628a7edc

Molecular analyses define Vα7.2-Jα33+ MAIT-cell depletion in HIV infection: a case-control study

Autor: Klenerman, P, Ussher, JE, Phalora, P, Cosgrove, C, Hannaway, R, Rauch, A, Günthard, HF, Goulder, P, Phillips, RE, Willberg, CB

Publikováno v: Medicine.

MAIT-cells are an abundant anti-bacterial innate-like lymphocyte population. There are conflicting reports as to their fate in HIV infection. In this case-control study, we used quantitative real-time PCR to assess the abundance of mRNA and genomic D

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______1064::bdd71519a0e3e48b14d1a888f79cd8c3
http://ora.ox.ac.uk/objects/uuid:51548727-a638-4b74-b9c6-a3fd02b2472c

The SARS-CoV-2 neutralising antibody profile of New Zealand adults in 2023: Impact of vaccination and infection.

Autor: McGregor R; School of Medical Sciences, Faculty of Medical and Health Sciences, The University of Auckland, Auckland, New Zealand., Paterson A; School of Medical Sciences, Faculty of Medical and Health Sciences, The University of Auckland, Auckland, New Zealand., Lavender B; Vaccine Alliance Aotearoa New Zealand and Malaghan Institute of Medical Research, Wellington, New Zealand., Hooker C; Vaccine Alliance Aotearoa New Zealand and Malaghan Institute of Medical Research, Wellington, New Zealand., Frampton C; Christchurch Heart Institute, The University of Otago, Christchurch, New Zealand., Wiig K; Vaccine Alliance Aotearoa New Zealand and Malaghan Institute of Medical Research, Wellington, New Zealand., Le Gros G; Vaccine Alliance Aotearoa New Zealand and Malaghan Institute of Medical Research, Wellington, New Zealand., Ussher JE; Vaccine Alliance Aotearoa New Zealand and Malaghan Institute of Medical Research, Wellington, New Zealand; Department of Microbiology and Immunology, The University of Otago, Dunedin, New Zealand., Brewerton M; Vaccine Alliance Aotearoa New Zealand and Malaghan Institute of Medical Research, Wellington, New Zealand; Department of Clinical Immunology & Allergy, Auckland City Hospital, Te Whatu Ora - Health New Zealand, Auckland, New Zealand., Moreland NJ; School of Medical Sciences, Faculty of Medical and Health Sciences, The University of Auckland, Auckland, New Zealand. Electronic address: n.moreland@auckland.ac.nz.

Publikováno v: Vaccine [Vaccine] 2024 Oct 29; Vol. 42 (26), pp. 126482. Date of Electronic Publication: 2024 Oct 29.

Molecular and clinical epidemiology of carbapenem resistant Acinetobacter baumannii , Pseudomonas aeruginosa and Enterobacterales in Fiji: a multicentre prospective observational study.

Autor: Baleivanualala SC; Department of Microbiology and Immunology, School of Biomedical Sciences, University of Otago, Dunedin 9054, New Zealand.; College of Medicine, Nursing and Health Science, Fiji National University, Suva, Fiji.; Maurice Wilkins Centre for Molecular Biodiscovery, University of Auckland, Auckland 92019, New Zealand., Matanitobua S; Ministry of Health, Fiji., Soqo V; Ministry of Health, Fiji., Smita S; Ministry of Health, Fiji., Limaono J; Ministry of Health, Fiji., Sharma SC; Ministry of Health, Fiji., Devi SV; College of Medicine, Nursing and Health Science, Fiji National University, Suva, Fiji., Boseiwaqa LV; Ministry of Health, Fiji.; Aspen Medical, Lautoka, Fiji., Vera N; College of Medicine, Nursing and Health Science, Fiji National University, Suva, Fiji., Kumar S; Ministry of Health, Fiji., Lalibuli A; Ministry of Health, Fiji., Mailulu J; Pacific Laboratory Specialists, Suva, Fiji., Wilson D; College of Medicine, Nursing and Health Science, Fiji National University, Suva, Fiji., Samisoni Y; Aspen Medical, Lautoka, Fiji., Crump JA; Division of Health Sciences, Centre for International Health, University of Otago, Dunedin, New Zealand.; Otago Global Health Institute, University of Otago, Dunedin 9054, New Zealand., Ussher JE; Department of Microbiology and Immunology, School of Biomedical Sciences, University of Otago, Dunedin 9054, New Zealand.; Maurice Wilkins Centre for Molecular Biodiscovery, University of Auckland, Auckland 92019, New Zealand.; Otago Global Health Institute, University of Otago, Dunedin 9054, New Zealand.; Awanui Labs, Dunedin Hospital, Dunedin, New Zealand.

Publikováno v: The Lancet regional health. Western Pacific [Lancet Reg Health West Pac] 2024 May 29; Vol. 47, pp. 101095. Date of Electronic Publication: 2024 May 29 (Print Publication: 2024).

Molecular and clinical epidemiology of carbapenem resistant Acinetobacter baumannii ST2 in Oceania: a multicountry cohort study.

Autor: Baleivanualala SC; Department of Microbiology and Immunology, School of Biomedical Sciences, University of Otago, Dunedin 9054, New Zealand.; College of Medicine, Nursing and Health Science, Fiji National University, Suva, Fiji.; Maurice Wilkins Centre for Molecular Biodiscovery, University of Auckland, Auckland 92019, New Zealand., Isaia L; Department of Microbiology and Immunology, School of Biomedical Sciences, University of Otago, Dunedin 9054, New Zealand.; Maurice Wilkins Centre for Molecular Biodiscovery, University of Auckland, Auckland 92019, New Zealand.; Tupua Tamasese Mea'ole Hospital, Apia, Samoa., Devi SV; College of Medicine, Nursing and Health Science, Fiji National University, Suva, Fiji., Howden B; Microbiological Diagnostic Unit, Peter Doherty Institute for Infection & Immunity, University of Melbourne, Melbourne, Victoria 3000, Australia.; Department of Microbiology & Immunology, Peter Doherty Institute for Infection & Immunity, University of Melbourne, Melbourne, Victoria 3000, Australia., Gorrie CL; Microbiological Diagnostic Unit, Peter Doherty Institute for Infection & Immunity, University of Melbourne, Melbourne, Victoria 3000, Australia.; Department of Microbiology & Immunology, Peter Doherty Institute for Infection & Immunity, University of Melbourne, Melbourne, Victoria 3000, Australia., Matanitobua S; Fiji Centre for Disease Control, Tamavua, Suva, Fiji., Sharma S; Colonial War Memorial Hospital, Suva, Fiji., Wilson D; College of Medicine, Nursing and Health Science, Fiji National University, Suva, Fiji., Kumar S; Colonial War Memorial Hospital, Suva, Fiji., Maharaj K; Colonial War Memorial Hospital, Suva, Fiji., Beatson S; Australian Infectious Diseases Research Centre, University of Queensland, Brisbane, Queensland 4072, Australia., Boseiwaqa LV; Colonial War Memorial Hospital, Suva, Fiji., Dyet K; Institute of Environmental Science and Research Ltd., Porirua 5022, New Zealand., Crump JA; Otago Global Health Institute, University of Otago, Dunedin 9054, New Zealand., Hill PC; Maurice Wilkins Centre for Molecular Biodiscovery, University of Auckland, Auckland 92019, New Zealand.; Otago Global Health Institute, University of Otago, Dunedin 9054, New Zealand., Ussher JE; Department of Microbiology and Immunology, School of Biomedical Sciences, University of Otago, Dunedin 9054, New Zealand.; Maurice Wilkins Centre for Molecular Biodiscovery, University of Auckland, Auckland 92019, New Zealand.; Southern Community Laboratories, Dunedin Hospital, Dunedin 9016, New Zealand.

Publikováno v: The Lancet regional health. Western Pacific [Lancet Reg Health West Pac] 2023 Sep 22; Vol. 40, pp. 100896. Date of Electronic Publication: 2023 Sep 22 (Print Publication: 2023).